66 / 96
66
Informaciones
Psiquiátricas
2019 - n.º
236
46. Encuesta Europea de Salud en Espa-
ña EESE 2014. Ministerio de Sanidad,
Servicios Sociales e Igualdad. Disponi-
ble en el portal estadístico del SNS del
Ministerio de Sanidad.
47. American Diabetes Association; Ameri-
can Psychiatric Association; American
Association of Clinical Endocrinolo-
gists; North American Association for
the Study of Obesity. Consensus deve-
lopment conference on antipsychotic
drugs and obesity and diabetes. Diabe-
tes Care. 2004 Feb;27(2):596-601.
48. Rodríguez –Artalejo F, Baca E, Esmatjes
E, Merino-Torres JF, Monereo S, Moreno
B, et al. Valoración y control del riesgo
metabólico y cardiovascular en los
pacientes con esquizofrenia. Med Clin
(Barc). 2006 Oct 14;127(14):542-8.
49. De Hert M, Correll CU, Bobes J,
Cetkovich-Bakmas M, CohenD, Asai I,
et al. Physical illness in patients with
severe mental disorders. I. Prevalence,
impact of medications and disparities
in health care. World Psychiatry 2011
Feb;10(1):52-77.
50. Correll CU, Detraux J, De Lepeleire J,
De Hert M. Effects of antipsychotics,
antidepressants and mood stabilizers
on risk for physical diseases in people
with schizophrenia, depression and
bipolar disorder. World Psychiatry 2015
Jun;14(2):119-136.
51. Segura B, Jurado MA. Síndrome meta-
bólico y envejecimiento: déficit cog-
nitivo y alteraciones estructurales del
sistema nervioso central. Rev Neurol
2009;49(8):417-424.
52. Bokura H, Yamaguchi S, Iijima K, Nagai
A, Oguro H. Metabolic syndrome is
associated with silent ischemic brain
lesions. Stroke. 2008 May;39(5):1607-
9.
53. Kawamoto R, Tomita H, Oka Y, Kodama
A. Metabolic syndrome as a predictor
of is chemic stroke in elderly persons.
Intern Med. 2005 Sep;44(9): 922-7.
54. Kwon H, Kim MJ, Lee S, Choi SH, Oh
B, Yoon B. Metabolic syndrome as an
independent risk factor of silent brain
infarction in health y people. Stroke.
2006 Feb; 37(2): 466-70.
55. Reitz C, Tang MX, Manly J, Mayeux R,
Luchsinger JA. Hypertension and the
risk of mild cognitive impairment. Arch
Neurol. 2007 Dic;64(12).1734-40.
56. López Pérez-Díaz AG, Jiménez-Jáimez
J. La hipertensión arterial como factor
de riesgo para el deterioro cognitivo
en la vejez: estudio de revisión. Psico-
geriatría 2011; 3 (1): 19-28.
57. Whitmer RA, Gunderson EP, Barrett-
Connor E, Quessenberry CP Jr, Yaffe K.
Obesity in middle age and future risk
of dementia: a 27 year longitudinal
population based study. BMJ. 2005 Jun
11;330(7504):1360.
58. Muñoz G, Degen C, Schröder J, Toro P.
Diabetes Mellitus y su asociación con
deterioro cognitivo y demência. Med
Clin Condes 2016;27(2):266-270.
59. McCrimmon RJ, Ryan CM, Frier BM. Dia-
betes and cognitive dysfunction. Lancet.
2012 Jun 16;379 (9833):2291-9.
Emilio González-Pablos / Rosa Sanguino-Andrés / José A López-Villalobos / Federico Iglesias-Santa Polonia /
Guillermo Hoyos-Villagrá / Clara González-Sanguino / Carlos Martín-Lorenzo